Glaxo SmithKline and FAPESP launches call for health research

The Foundation for Research Support of São Paulo and Brazil-Glaxo SmithKline (GSK) launched call for proposals for research under the cooperation agreement signed on February 28 institutions. The agreement will allow a contribution of funds up to $ 600,000, with a maximum approved for each project limited to $ 200,000, shared equally by GSK and FAPESP, to support research in the area of ​​Health developed in the State of Paul.

The priority areas for the development of collaborative research include topics such as respiratory diseases, metabolic, infectious, inflammatory and immunology, as well as tropical and neglected diseases and so-called rare diseases.

Other themes and subthemes relevant to public health in Brazil, including the application in the development of new drugs, may also be the object of the projects according to needs verified by a steering committee consisting of members of the cooperation of both institutions.

The purpose of the call is to promote research projects that lead to new knowledge, contributing to the construction of scientific and technological skills in health, with results that could potentially lead to applications with a market value in the areas covered.

May submit projects researchers from institutions of higher education and research, public and private, in the State of Sao Paulo. Conditions will apply the Support Program for Research in Partnership for Technological Innovation (PITE) of FAPESP. The research projects will be received until May 14.

The collaboration between GSK and FAPESP Brazil takes place within the Trust in Science Project, an international initiative that Glaxo SmithKline plans to invest $ 3 million in cooperative agreements with the subsequent FAPESP and also with the National Council for Scientific and Technological Development ( CNPq).

• Tweet